Stocks News

LAST PRICE
325.0500
TODAY'S CHANGE (%)
Trending Up2.1900 (0.6783%)

Bid / Lots
320.6500/ 1
Ask / Lots
329.3600/ 1
Open / Previous Close
324.0200 / 322.8600
Day Range
Low 321.4850
High 325.3100
52 Week Range
Low 215.9600
High 335.8300
Volume
725,916
below average

Search Criteria

Click on magnifying glass icon to search

Search Criteria - - - Stocks (0)
Company	Country	Symbol

TD Direct Investing offers more research reports than any other discount brokerage in Canada. Provided from the industry's most trusted sources, our service includes timely, relevant information for the current trading day and comprehensive industry, sector, and insider trading reports for further analysis.

Open a New Account, or Login if you're a client.

Today
- Hca Healthcare Insider Sold Shares Worth $1,045,465, According to a Recent SEC Filing, from 38 minutes ago by MT Newswires
  38 minutes ago by MT Newswires
  Companies Mentioned: HCA
  05:25 PM EDT, 05/20/2024 (MT Newswires) -- Kathleen M Whalen, Senior Vice President & Chief Ethics Officer, on May 16, 2024, sold 3,204 shares in Hca Healthcare (HCA) for $1,045,465. Following the Form 4 filing with the SEC, Whalen has control over ...
- UBS Raises HCA Healthcare Price Target to $377 From $363, Maintains Buy Rating, from 7 hours ago by MT Newswires
  7 hours ago by MT Newswires
  Companies Mentioned: HCA
  10:36 AM EDT, 05/20/2024 (MT Newswires) -- HCA Healthcare (HCA) has an average rating of outperform and price targets ranging from $285 to $378, according to analysts polled by Capital IQ. (MT Newswires covers equity, commodity and economic research...
May 14, 2024
- DBS Bank Initiates HCA Healthcare at Buy Rating With $370 Price Target, from 9:31AM ET on Tuesday May 14, 2024 by MT Newswires
  9:31AM ET on Tuesday May 14, 2024 by MT Newswires
  Companies Mentioned: HCA
  09:31 AM EDT, 05/14/2024 (MT Newswires) -- HCA Healthcare (HCA) has an average outperform rating and a price target range of $285 to $378, according to analysts polled by Capital IQ. (MT Newswires covers equity, commodity and economic research from ...
May 13, 2024
- Hca Healthcare Insider Sold Shares Worth $516,450, According to a Recent SEC Filing, from 5:12PM ET on Monday May 13, 2024 by MT Newswires
  5:12PM ET on Monday May 13, 2024 by MT Newswires
  Companies Mentioned: HCA
  05:12 PM EDT, 05/13/2024 (MT Newswires) -- Jeffrey E. Cohen, Senior Vice President, Government Relations, on May 09, 2024, sold 1,650 shares in Hca Healthcare (HCA) for $516,450. Following the Form 4 filing with the SEC, Cohen has control over a tot...
- Hca Healthcare Insider Sold Shares Worth $1,999,825, According to a Recent SEC Filing, from 5:11PM ET on Monday May 13, 2024 by MT Newswires
  5:11PM ET on Monday May 13, 2024 by MT Newswires
  Companies Mentioned: HCA
  05:11 PM EDT, 05/13/2024 (MT Newswires) -- Michael S. Cuffe, Executive Vice President and Chief Clinical Officer, on May 09, 2024, sold 6,311 shares in Hca Healthcare (HCA) for $1,999,825. Following the Form 4 filing with the SEC, Cuffe has control ...

Today
- UBS Adjusts Tenet Healthcare Price Target to $164 From $150, Maintains Buy Rating, from 7 hours ago by MT Newswires
  7 hours ago by MT Newswires
  Companies Mentioned: THC
- BMO Capital Adjusts Ventas Price Target to $53 From $51, from 10 hours ago by MT Newswires
  10 hours ago by MT Newswires
  Companies Mentioned: VTR
May 16, 2024
- Laboratory Corp Of America Holdings Insider Sold Shares Worth $421,655, According to a Recent SEC Filing, from 8:27AM ET on Thursday May 16, 2024 by MT Newswires
  8:27AM ET on Thursday May 16, 2024 by MT Newswires
  Companies Mentioned: LH
- Scotiabank Adjusts Price Target on Ventas to $51 From $47, from 7:44AM ET on Thursday May 16, 2024 by MT Newswires
  7:44AM ET on Thursday May 16, 2024 by MT Newswires
  Companies Mentioned: VTR
- Scotiabank Adjusts Price Target on Welltower to $108 From $96, from 7:38AM ET on Thursday May 16, 2024 by MT Newswires
  7:38AM ET on Thursday May 16, 2024 by MT Newswires
  Companies Mentioned: WELL
- Morgan Stanley Adjusts Price Target on Ventas to $49 From $47, Keeps Equalweight Rating, from 5:54AM ET on Thursday May 16, 2024 by MT Newswires
  5:54AM ET on Thursday May 16, 2024 by MT Newswires
  Companies Mentioned: VTR
- Baird Adjusts Price Target on Laboratory Corp of America Holdings to $256 From $255, Keeps Outperform Rating, from 5:42AM ET on Thursday May 16, 2024 by MT Newswires
  5:42AM ET on Thursday May 16, 2024 by MT Newswires
  Companies Mentioned: LH
May 15, 2024
- Morgan Stanley Adjusts Price Target on Welltower to $103 From $102, from 10:27AM ET on Wednesday May 15, 2024 by MT Newswires
  10:27AM ET on Wednesday May 15, 2024 by MT Newswires
  Companies Mentioned: WELL
- Labcorp Introduces First Trimester Screening Test to Assess Preeclampsia Risk during Pregnancy, from 8:00AM ET on Wednesday May 15, 2024 by PR Newswire
  8:00AM ET on Wednesday May 15, 2024 by PR Newswire
  Companies Mentioned: LH
- --Ventas Maintains Quarterly Dividend at $0.45 per Share; Payable July 18 to Shareholders of Record on July 1, from 3:57AM ET on Wednesday May 15, 2024 by MT Newswires
  3:57AM ET on Wednesday May 15, 2024 by MT Newswires
  Companies Mentioned: VTR

HCA Healthcare Inc
NYSE:HCAUnited States

Search Criteria

Today

Hca Healthcare Insider Sold Shares Worth $1,045,465, According to a Recent SEC Filing, from 38 minutes ago by MT Newswires

UBS Raises HCA Healthcare Price Target to $377 From $363, Maintains Buy Rating, from 7 hours ago by MT Newswires

May 14, 2024

DBS Bank Initiates HCA Healthcare at Buy Rating With $370 Price Target, from 9:31AM ET on Tuesday May 14, 2024 by MT Newswires

May 13, 2024

Hca Healthcare Insider Sold Shares Worth $516,450, According to a Recent SEC Filing, from 5:12PM ET on Monday May 13, 2024 by MT Newswires

Hca Healthcare Insider Sold Shares Worth $1,999,825, According to a Recent SEC Filing, from 5:11PM ET on Monday May 13, 2024 by MT Newswires

Peers Headlines

Today

UBS Adjusts Tenet Healthcare Price Target to $164 From $150, Maintains Buy Rating, from 7 hours ago by MT Newswires

BMO Capital Adjusts Ventas Price Target to $53 From $51, from 10 hours ago by MT Newswires

May 16, 2024

Laboratory Corp Of America Holdings Insider Sold Shares Worth $421,655, According to a Recent SEC Filing, from 8:27AM ET on Thursday May 16, 2024 by MT Newswires

Scotiabank Adjusts Price Target on Ventas to $51 From $47, from 7:44AM ET on Thursday May 16, 2024 by MT Newswires

Scotiabank Adjusts Price Target on Welltower to $108 From $96, from 7:38AM ET on Thursday May 16, 2024 by MT Newswires

Morgan Stanley Adjusts Price Target on Ventas to $49 From $47, Keeps Equalweight Rating, from 5:54AM ET on Thursday May 16, 2024 by MT Newswires

Baird Adjusts Price Target on Laboratory Corp of America Holdings to $256 From $255, Keeps Outperform Rating, from 5:42AM ET on Thursday May 16, 2024 by MT Newswires

May 15, 2024

Morgan Stanley Adjusts Price Target on Welltower to $103 From $102, from 10:27AM ET on Wednesday May 15, 2024 by MT Newswires

Labcorp Introduces First Trimester Screening Test to Assess Preeclampsia Risk during Pregnancy, from 8:00AM ET on Wednesday May 15, 2024 by PR Newswire

--Ventas Maintains Quarterly Dividend at $0.45 per Share; Payable July 18 to Shareholders of Record on July 1, from 3:57AM ET on Wednesday May 15, 2024 by MT Newswires